| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0JSR7Z0NB6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Epidermal growth factor receptor erbB1 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297774 |
| FDA SRS | 0JSR7Z0NB6 |
CONTENTS